5-Amino-IMQ is a small peptide compound recognized for its role in supporting metabolic function, especially in regulating energy balance and fat utilization. Its primary mechanism involves inhibiting the enzyme nicotinamide N-methyltransferase (NNMT), which is important in cellular metabolic processes. By suppressing NNMT activity, 5-Amino-1MQ elevates levels of nicotinamide and related molecules within cells, potentially improving mitochondrial performance and encouraging the use of stored fat as an energy source. This action makes it a compelling option for promoting weight management and enhancing metabolic efficiency.

​

Within the body, NNMT inhibition triggered by 5-Amino-1MQ sets off a series of positive effects related to energy use and fat tissue regulation. As the body begins to mobilize fat stores and increase overall energy expenditure, this may lead to reductions in body fat and improvements in metabolic health. Increased cellular energy output can also contribute to better physical performance and recovery. This peptide is generally administered via subcutaneous injection and is commonly used in cycles to optimize its metabolic effects while helping to limit potential side effects.